|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
36,010,000 |
Market
Cap: |
445.80(M) |
Last
Volume: |
129,261 |
Avg
Vol: |
128,911 |
52
Week Range: |
$9.69 - $21.36 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Orthofix Medical is a medical device company. Co.'s Global Spine segment provides implantable medical devices, biologics, and other regenerative solutions. This segment's product categories include: Bone Growth Therapies, which manufactures, distributes, and provides support services for bone growth stimulation devices; Spinal Implants, which designs, develops and markets a portfolio of motion preservation and fixation implant products; and Biologics, which provides a portfolio of products and tissue forms. Co.'s Global Orthopedics segment provides products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
7,500 |
7,500 |
Total Buy Value |
$0 |
$0 |
$101,025 |
$101,025 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
0 |
0 |
0 |
12,505 |
Total Sell Value |
$0 |
$0 |
$0 |
$232,268 |
Total People Sold |
0 |
0 |
0 |
2 |
Total Sell Transactions |
0 |
0 |
0 |
3 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Doug Rice |
CFO |
|
2022-04-01 |
4 |
D |
$33.04 |
$84,880 |
D/D |
(2,569) |
93,105 |
|
- |
|
Kenny Kevin J |
President of Global Spine |
|
2022-04-01 |
4 |
D |
$33.04 |
$64,593 |
D/D |
(1,955) |
54,688 |
|
- |
|
Serbousek Jon Carl |
CEO |
|
2022-04-01 |
4 |
D |
$33.04 |
$196,258 |
D/D |
(5,940) |
188,839 |
|
- |
|
Gonsalves Paul |
President, Global Orthopedics |
|
2022-04-01 |
4 |
D |
$33.04 |
$22,698 |
D/D |
(687) |
25,716 |
|
- |
|
Kenny Kevin J |
President of Global Spine |
|
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,492 |
56,643 |
|
- |
|
Gonsalves Paul |
President, Global Orthopedics |
|
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,836 |
26,403 |
|
- |
|
Doug Rice |
CFO |
|
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,131 |
95,674 |
|
- |
|
Serbousek Jon Carl |
CEO |
|
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
81,967 |
194,779 |
|
- |
|
Elting Kimberley A. |
Chief Legal & Develop. Officer |
|
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,492 |
67,295 |
|
- |
|
Keran Patrick L |
Chief Legal OfficerOfficer |
|
2022-01-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
54,070 |
|
-13% |
|
Kenny Kevin J |
President of Global Spine |
|
2021-12-04 |
4 |
D |
$30.24 |
$29,756 |
D/D |
(984) |
36,151 |
|
- |
|
Burzik Catherine M |
Director |
|
2021-11-19 |
4 |
B |
$30.27 |
$50,248 |
D/D |
1,660 |
7,947 |
2.39 |
7% |
|
Doug Rice |
CFO |
|
2021-11-19 |
4 |
B |
$30.05 |
$42,070 |
D/D |
1,400 |
73,543 |
2.74 |
7% |
|
Elting Kimberley A. |
Chief Legal & Develop. Officer |
|
2021-11-18 |
4 |
B |
$30.34 |
$30,340 |
D/D |
1,000 |
46,803 |
2.74 |
10% |
|
Serbousek Jon Carl |
CEO |
|
2021-11-18 |
4 |
B |
$31.14 |
$52,004 |
D/D |
1,670 |
112,812 |
2.81 |
10% |
|
Gonsalves Paul |
President, Global Orthopedics |
|
2021-09-11 |
4 |
D |
$40.59 |
$42,417 |
D/D |
(1,045) |
16,567 |
|
- |
|
Elting Kimberley A. |
Chief Legal & Develop. Officer |
|
2021-09-05 |
4 |
D |
$42.69 |
$15,582 |
D/D |
(365) |
44,953 |
|
- |
|
Serbousek Jon Carl |
CEO |
|
2021-08-05 |
4 |
D |
$37.98 |
$55,071 |
D/D |
(1,450) |
112,272 |
|
- |
|
Elting Kimberley A. |
Chief Legal & Develop. Officer |
|
2021-07-03 |
4 |
D |
$40.48 |
$14,006 |
D/D |
(346) |
45,318 |
|
- |
|
Doug Rice |
CFO |
|
2021-07-03 |
4 |
D |
$40.48 |
$15,099 |
D/D |
(373) |
70,370 |
|
- |
|
Sicard John |
Director |
|
2021-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,313 |
15,232 |
|
- |
|
Hinrichs James F. |
Director |
|
2021-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,313 |
55,594 |
|
- |
|
Paolucci Michael E |
Director |
|
2021-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,313 |
24,814 |
|
- |
|
Lukianov Alexis V |
Director |
|
2021-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,313 |
21,027 |
|
- |
|
Marks Lilly |
Director |
|
2021-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,313 |
30,573 |
|
- |
|
362 Records found
|
|
Page 5 of 15 |
|
|